Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK)
申请人:Sugen, Inc.
公开号:US20040266843A1
公开(公告)日:2004-12-30
The present invention relates generally to the field of radiosensitizing agents which are capable of enhancing radiotherapy by inhibiting DNA-PK (DNA-protein kinase). In particular, it relates to sulfonamide substituted indolinones which inhibit DNA-PK.
本发明通常涉及放射增敏剂领域,这些放射增敏剂能够通过抑制DNA-PK(DNA-蛋白激酶)来增强放射疗法。具体而言,涉及抑制DNA-PK的磺胺基取代吲哚酮。